Lutzomyia longipalpis saliva or salivary protein LJM19 protects against Leishmania braziliensis and the saliva of its vector, Lutzomyia intermedia

PLoS Neglected Tropical Diseases

Volumn 5, Issue 5, 2011, Pages

  Tavares, Natalia M ^a   Silva, Robson A ^b   Costa, Dirceu J ^a   Pitombo, Maiana A ^a   Fukutani, Kiyoshi F ^a   Miranda, José C ^a   Valenzuela, Jesus G ^c   Barral, Aldina ^a,d   de Oliveira, Camila I ^a,d   Barral Netto, Manoel ^a,d   Brodskyn, Claudia ^a,d  

^a INSTITUTO OSWALDO CRUZ   (Brazil)

^b FEDERAL UNIVERSITY OF BAHIA   (Brazil)

^c NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES   (United States)

^d Instituto de Investigacao em Imunologia   (Brazil)

Author keywords

[No Author keywords available]

Indexed keywords

GAMMA INTERFERON; INTERLEUKIN 10; LEISHMANIA VACCINE; NATURAL PRODUCT; PLASMID DNA; PROTEIN LJM19; TRANSFORMING GROWTH FACTOR BETA; UNCLASSIFIED DRUG; DNA VACCINE; PROTOZOAL VACCINE; SALIVA PROTEIN;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CONTROLLED STUDY; DRUG SCREENING; HAMSTER; IMMUNE RESPONSE; IMMUNIZATION; LEISHMANIA BRAZILIENSIS; LEISHMANIASIS; LUTZOMYIA; LUTZOMYIA INTERMEDIA; LUTZOMYIA LONGIPALPIS; MALE; NONHUMAN; OUTCOME ASSESSMENT; PARASITE IDENTIFICATION; PARASITE TRANSMISSION; PROTEIN EXPRESSION; PSYCHODIDAE; VISCERAL LEISHMANIASIS; ANIMAL; CHEMISTRY; DISEASE TRANSMISSION; FEMALE; IMMUNOLOGY; ISOLATION AND PURIFICATION; LYMPH NODE; PARASITOLOGY; PATHOLOGY; SALIVA; SECRETION; SKIN; SKIN LEISHMANIASIS; SYRIAN HAMSTER;

ANIMALS; CRICETINAE; DISEASE TRANSMISSION, INFECTIOUS; FEMALE; INTERFERON-GAMMA; INTERLEUKIN-10; LEISHMANIA BRAZILIENSIS; LEISHMANIASIS, CUTANEOUS; LYMPH NODES; MALE; MESOCRICETUS; PROTOZOAN VACCINES; PSYCHODIDAE; SALIVA; SALIVARY PROTEINS AND PEPTIDES; SKIN; VACCINES, DNA;

EID: 79957999606     PISSN: 19352727     EISSN: 19352735     Source Type: Journal    
DOI: 10.1371/journal.pntd.0001169     Document Type: Article

References (27)

1. Bittencourt A, Barral-Netto M, (1991) Evaluation of the histopathological classifications of American cutaneous and mucocutaneous leishmaniasis. Mem. Inst. Oswaldo Cruz 86: 51-56.
2. Ribeiro JM, Francischetti IM, (2001) Platelet-activating-factor-hydrolyzing phospholipase C in the salivary glands and saliva of the mosquito Culex quinquefasciatus. The Journal of experimental biology 204: 3887-94.
3. Andrade BB, Oliveira CI de, Brodskyn CI, Barral A, Barral-Netto M, (2007) Role of sand fly saliva in human and experimental leishmaniasis: current insights. Scandinavian journal of immunology 66: 122-7.
4. Titus RG, Ribeiro JM, (1988) Salivary gland lysates from the sand fly Lutzomyia longipalpis enhance Leishmania infectivity. Science (New York, N.Y.) 239: 1306-8.
5. Moura Tde, Oliveira F, Novais FO, Miranda J, Clarêncio J, et al. (2007) Enhanced Leishmania braziliensis infection following pre-exposure to sandfly saliva. PLoS Negl Trop Dis.
6. Labuda M, Jones LD, Williams T, Nuttall PA, (1993) Enhancement of tick-borne encephalitis virus transmission by tick salivary gland extracts. Medical and veterinary entomology 7: 193-6.
7. Kamhawi S, Belkaid Y, Modi G, Rowton E, Sacks D, (2000) Protection against cutaneous leishmaniasis resulting from bites of uninfected sand flies. Science (New York, N.Y.) 290: 1351-4.
8. Valenzuela JG, Belkaid Y, Garfield MK, Mendez S, Kamhawi S, et al. (2001) Toward a defined anti-Leishmania vaccine targeting vector antigens: characterization of a protective salivary protein. The Journal of experimental medicine 194: 331-42.
9. Gomes R, Teixeira C, Teixeira MJ, Oliveira F, Menezes MJ, et al. (2008) Immunity to a salivary protein of a sand fly vector protects against the fatal outcome of visceral leishmaniasis in a hamster model. Proceedings of the National Academy of Sciences of the United States of America 105: 7845-50.
10. Belkaid Y, Valenzuela JG, Kamhawi S, Rowton E, Sacks DL, et al. (2000) Delayed-type hypersensitivity to Phlebotomus papatasi sand fly bite: An adaptive response induced by the fly? Proceedings of the National Academy of Sciences of the United States of America 97: 6704-9.
11. Valenzuela JG, Garfield MK, Rowton ED, Pham V, (2004) Identification of the most abundant secreted proteins from the salivary glands of the sand fly Lutzomyia longipalpis, vector of Leishmania chagasi. J Exp Biol 207: 3717-29.
12. Modi G, Tesh R, (1983) A simple technique for mass rearing Lutzomyia longipalpis and Phlebotomus papatasi (Diptera: Psychodidae) in the laboratory. J Med Entomol 20: 568-9.
13. Oliveira F, Kamhawi S, Seitz A, Pham V, Guigal P, et al. (2006) From transcriptome to immunome: identification of DTH inducing proteins from a Phlebotomus ariasi salivary gland cDNA library. Vaccine 24: 374-90.
14. Bradford MM, (1976) A rapid and sensitive method for the quantitation of microgram quantities of protein utilizing the principle of protein-dye binding. Analytical biochemistry 72: 248-54.
15. Titus RG, Marchand M, Boon T, Louis J, (1985) A limiting dilution assay for quantifying Leishmania major in tissues of infected mice. Parasite Immunol 7: 545-555.
16. Herrer A, Telford S, Christensen H, (1979) Leishmania braziliensis: dissemination of Panamanian strains in golden hamsters. Exp Parasitol 48: 359-63.
17. Wilson R, Dieckmann B, Childs G, (1979) Leishmania braziliensis and Leishmania mexicana: experimental cutaneous infections in golden hamsters. Exp Parasitol 47: 270-83.
18. Belkaid Y, Kamhawi S, Modi G, Valenzuela J, Noben-Trauth N, et al. (1998) Development of a natural model of cutaneous leishmaniasis: powerful effects of vector saliva and saliva preexposure on the long-term outcome of Leishmania major infection in the mouse ear dermis. The Journal of experimental medicine 188: 1941-53.
19. Collin N, Gomes R, Teixeira C, Cheng L, Laughinghouse A, et al. (2009) Sand fly salivary proteins induce strong cellular immunity in a natural reservoir of visceral leishmaniasis with adverse consequences for Leishmania. PLoS pathogens 5: e1000441.
20. Oliveira CI, Teixeira MJ, Teixeira CR, Jesus JR, Rosato AB, et al. (2004) Leishmania braziliensis isolates differing at the genome level display distinctive features in BALB/c mice. Microbes and infection/ Institut Pasteur 6: 977-84.
21. Teixeira MJ, Fernandes JD, Teixeira CR, Andrade BB, Pompeu ML, et al. (2005) Distinct Leishmania braziliensis isolates induce different paces of chemokine expression patterns. Infection and immunity 73: 1191-5.
22. Lima HC, Titus RG, (1996) Effects of sand fly vector saliva on development of cutaneous lesions and the immune response to Leishmania braziliensis in BALB/c mice. Infection and immunity 64: 5442-5.
23. Thiakaki M, Rohousova I, Volfova V, Volf P, Chang K-P, et al. (2005) Sand fly specificity of saliva-mediated protective immunity in Leishmania amazonensis-BALB/c mouse model. Microbes and infection/ Institut Pasteur 7: 760-6.
24. Costa DJ, Favali C, Clarêncio J, Afonso L, Conceição V, et al. (2004) Lutzomyia longipalpis salivary gland homogenate impairs cytokine production and costimulatory molecule expression on human monocytes and dendritic cells. Infection and immunity 72: 1298-305.
25. Melby PC, Tabares A, Restrepo BI, Cardona AE, McGuff HS, et al. (2001) Leishmania donovani: evolution and architecture of the splenic cellular immune response related to control of infection. Experimental parasitology 99: 17-25.
26. Moura TR de, Oliveira F, Rodrigues GC, Carneiro MW, Fukutani KF, et al. (2010) Immunity to Lutzomyia intermedia Saliva Modulates the Inflammatory Environment Induced by Leishmania braziliensis. PLoS Neglected Tropical Diseases 4: e712.
27. Araújo-Santos T, Prates DB, Andrade BB, Nascimento DO, Clarêncio J, et al. (2010) Lutzomyia longipalpis Saliva Triggers Lipid Body Formation and Prostaglandin E(2) Production in Murine Macrophages. PLoS neglected tropical diseases 4: e873.